印度改变脊髓灰质炎根除策略带来的疲劳和恐惧：对疫苗接种社会抵制的研究。
Fatigue and fear with shifting polio eradication strategies in India: a study of social resistance to vaccination.
机构信息
Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
出版信息
PLoS One. 2012;7(9):e46274. doi: 10.1371/journal.pone.0046274. Epub 2012 Sep 26.
Abstract
Shifting polio eradication strategies may have generated fear and "resistance" to the eradication program in Aligarh, India during the summer of 2009. Participant observation and formal interviews with 107 people from May to August 2009 indicated that the intensified frequency of vaccination was correlated with patients' doubt in the efficacy of the vaccine. This doubt was exacerbated in a few cases as families were uninformed of the use of monovalent mOPV1, while P3 cases continued to occur. Many families had also come to believe that their children had been adversely affected by OPV after being told the vaccine carried no risk. Though polio is now largely eradicated in India, with only a single case in 2011, greater transparency about changes with vaccination policy may need to be considered to build trust with the public in future eradication programs.
摘要
2009 年夏季，印度阿拉哈巴德改变脊髓灰质炎根除策略，可能引发民众对根除计划的恐惧和“抵触”。2009 年 5 月至 8 月，通过对 107 人进行参与性观察和正式访谈发现，疫苗接种频率的增加与患者对疫苗效果的怀疑有关。在少数情况下，由于未告知使用单价 mOPV1，而 P3 病例仍在继续发生，家庭对此表示怀疑。许多家庭还认为，在被告知疫苗没有风险后，他们的孩子接种 OPV 后受到了不良影响。尽管印度目前已基本根除脊髓灰质炎，2011 年仅出现一例病例，但未来根除计划可能需要考虑提高疫苗接种政策变化的透明度，以赢得公众的信任。
相似文献
1
Fatigue and fear with shifting polio eradication strategies in India: a study of social resistance to vaccination.印度改变脊髓灰质炎根除策略带来的疲劳和恐惧：对疫苗接种社会抵制的研究。
PLoS One. 2012;7(9):e46274. doi: 10.1371/journal.pone.0046274. Epub 2012 Sep 26.
2
OPV cannot eradicate polio from India: do we need any further evidence?口服脊髓灰质炎疫苗无法在印度根除脊髓灰质炎：我们还需要更多证据吗？
Vaccine. 2008 Apr 16;26(17):2058-61. doi: 10.1016/j.vaccine.2008.02.054. Epub 2008 Mar 14.
3
Partition and poliomyelitis: an investigation of the polio disparity affecting Muslims during India's eradication program.分区与小儿麻痹症：对印度根除计划期间影响穆斯林的小儿麻痹症差异的调查。
PLoS One. 2015 Mar 5;10(3):e0115628. doi: 10.1371/journal.pone.0115628. eCollection 2015.
4
Polio eradication in India: current status.印度的脊髓灰质炎根除工作：现状
J Indian Med Assoc. 2005 Dec;103(12):669-70, 678.
5
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.印度莫拉达巴德 6-9 月龄儿童补充剂量脊灰病毒疫苗的免疫原性：一项基于社区的随机对照试验。
Lancet Infect Dis. 2012 Feb;12(2):128-35. doi: 10.1016/S1473-3099(11)70190-6. Epub 2011 Nov 7.
6
Progress toward poliomyelitis eradication--Nigeria, 2005-2006.2005 - 2006年尼日利亚在根除脊髓灰质炎方面取得的进展
MMWR Morb Mortal Wkly Rep. 2007 Mar 30;56(12):278-81.
7
Role of genetic factors in polio eradication: new challenge for policy makers.遗传因素在根除脊髓灰质炎中的作用：政策制定者面临的新挑战。
Vaccine. 2007 Dec 5;25(50):8365-71. doi: 10.1016/j.vaccine.2007.09.068. Epub 2007 Oct 17.
8
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.用于预防脊髓灰质炎的序贯灭活脊髓灰质炎疫苗（IPV）和口服脊髓灰质炎减毒活疫苗（OPV）
Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2.
9
Some ethical issues arising from polio eradication programmes in India.印度脊髓灰质炎根除计划引发的一些伦理问题。
Bioethics. 2005 Aug;19(4):393-406. doi: 10.1111/j.1467-8519.2005.00451.x.
10
The polio endgame.脊髓灰质炎的终结之战。
Hum Vaccin Immunother. 2014;10(7):2106-8. doi: 10.4161/21645515.2014.981115.
引用本文的文献
1
Quantifiable Cross-cultural Research on Medical Mistrust is Necessary for Effective and Equitable Vaccination in Low- and Middle-income Countries.对医疗不信任进行可量化的跨文化研究对于低收入和中等收入国家有效且公平地开展疫苗接种工作而言是必要的。
J Epidemiol Glob Health. 2024 Dec;14(4):1771-1777. doi: 10.1007/s44197-024-00319-0. Epub 2024 Oct 28.
2
From both sides of the needle: Understanding effective interventions for facilitating non-national immunization program vaccine decision making in China.从针的两侧：了解中国促进非国家免疫规划疫苗决策的有效干预措施。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2389578. doi: 10.1080/21645515.2024.2389578. Epub 2024 Aug 22.
3
A Low-Cost, Integrated Immunization, Health, and Nutrition Intervention in Conflict Settings in Pakistan-The Impact on Zero-Dose Children and Polio Coverage.巴基斯坦冲突地区的低成本综合免疫、健康与营养干预措施——对零剂次儿童和脊髓灰质炎疫苗接种覆盖率的影响
Pathogens. 2024 Feb 20;13(3):185. doi: 10.3390/pathogens13030185.
4
Strengthening polio vaccine demand in Ghana: Understanding the factors influencing uptake of the vaccine and the effectiveness of different message frames.加强加纳脊髓灰质炎疫苗需求：了解影响疫苗接种率的因素以及不同信息框架的效果。
PLoS One. 2023 Feb 10;18(2):e0279809. doi: 10.1371/journal.pone.0279809. eCollection 2023.
5
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素：定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
6
A multi-pronged scoping review approach to understanding the evolving implementation of the Smallpox and Polio eradication programs: what can other Global Health initiatives learn?一种多管齐下的范围审查方法，以了解天花和脊髓灰质炎根除计划不断演变的实施情况：其他全球卫生倡议能学到什么？
BMC Public Health. 2020 Dec 18;20(Suppl 4):1698. doi: 10.1186/s12889-020-09439-1.
7
Parents' and informal caregivers' views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence.父母及非正式照料者关于儿童常规疫苗接种沟通的观点与经历：定性证据综述
Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011787. doi: 10.1002/14651858.CD011787.pub2.
8
Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.2014年尼日利亚卡杜纳州补充免疫活动期间青年团体在不合作社区的参与情况
J Infect Dis. 2016 May 1;213 Suppl 3(Suppl 3):S91-5. doi: 10.1093/infdis/jiv510. Epub 2015 Nov 25.
9
Partition and poliomyelitis: an investigation of the polio disparity affecting Muslims during India's eradication program.分区与小儿麻痹症：对印度根除计划期间影响穆斯林的小儿麻痹症差异的调查。
PLoS One. 2015 Mar 5;10(3):e0115628. doi: 10.1371/journal.pone.0115628. eCollection 2015.
10
Sustaining motivation to immunize: exchanging lessons between India and the United States.维持免疫接种的动力：印度与美国之间的经验交流
Hum Vaccin Immunother. 2014;10(10):2930-4. doi: 10.4161/hv.29871.
本文引用的文献
1
Polio Eradication in India: Myth or Reality.印度的脊髓灰质炎根除：神话还是现实。
Med J Armed Forces India. 2005 Oct;61(4):364-6. doi: 10.1016/S0377-1237(05)80069-3. Epub 2011 Jul 21.
2
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.二价 1 型和 3 型口服脊髓灰质炎疫苗的免疫原性：一项随机、双盲、对照试验。
Lancet. 2010 Nov 13;376(9753):1682-8. doi: 10.1016/S0140-6736(10)61230-5. Epub 2010 Oct 25.
3
Using data to guide action in polio health communications: experience from the Polio Eradication Initiative (PEI).利用数据指导脊灰健康传播行动：来自根除脊灰行动（PEI）的经验。
J Health Commun. 2010;15 Suppl 1:48-65. doi: 10.1080/10810731003698585.
4
The complexity of social mobilization in health communication: top-down and bottom-up experiences in polio eradication.健康传播中社会动员的复杂性：根除脊髓灰质炎中的自上而下和自下而上经验。
J Health Commun. 2010;15 Suppl 1:25-47. doi: 10.1080/10810731003695367.
5
Deconstructing social resistance to pulse polio campaign in two North Indian districts.解构印度北部两个地区针对脊髓灰质炎疫苗接种运动的社会抵制。
Indian Pediatr. 2009 Nov;46(11):963-74. Epub 2009 Sep 3.
6
Progress toward interruption of wild poliovirus transmission--worldwide, 2008.2008年全球野生脊髓灰质炎病毒传播阻断进展
MMWR Morb Mortal Wkly Rep. 2009 Apr 3;58(12):308-12.
7
Social determinants and polio 'endgame': a qualitative study in high risk districts of India.社会决定因素与脊髓灰质炎“收官之战”：印度高危地区的定性研究
Indian Pediatr. 2008 May;45(5):357-65.
8
Reducing resistance against polio drops.
J R Soc Promot Health. 2007 Nov;127(6):276-9. doi: 10.1177/1466424007083705.
9
Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.单价口服1型脊髓灰质炎病毒疫苗的保护效力：一项病例对照研究
Lancet. 2007 Apr 21;369(9570):1356-1362. doi: 10.1016/S0140-6736(07)60531-5.
10
Infectious disease. Polio: no cheap way out.
Science. 2007 Apr 20;316(5823):362-3. doi: 10.1126/science.316.5823.362.
Zotero 插件